Disc Medicine, Inc. Stock: price and management transactions · United States · SEC (Form 4)Follow the Disc Medicine, Inc. share price and the full insider trade history of the company, a listed issuer based in United States. Shares are quoted on the US market, under the supervision of SEC (Form 4). Market capitalisation: €3.1bn. The latest transaction was filed on 9 September 2026 (Cession). Among the most active insiders: Bitterman Kevin. The full history is openly available.
Analyst consensus: bullish or bearish? Analysts rate Disc Medicine, Inc. Strong Buy (bullish), based on 12 analysts. Average price target: US$101.58.
This score ranks the purchase within its own market. No market currently meets the historical allocation criteria, so signals remain watch-only. Not investment advice.
Σ Sigma AI Analysis Fundamental view, insider signal, bull and bear case, synthesis.
AI analysis generation is paused.
Last declaration on 9 September 2026
All Executives204 Thresholds0 Prospectus0 Other0
Declarations 204 total
▼ Director · Executives · 4 Sept 2026
912 shares @ US$79.96 Common Stock SEC:0001591747-26-000005:0
▼ Director · Executives · 4 Sept 2026
759 shares @ US$79.96 Common Stock SEC:0001591747-26-000005:1
▼ Director · Executives · 4 Sept 2026
18 shares @ US$79.96 Common Stock SEC:0001591747-26-000005:2
● Shareholder · Executives · 4 Sept 2026
2,212 shares @ US$79.37 0.0057% mcap 24.3% of flow Common Stock SEC144:0001628280-26-060745
● Shareholder · Executives · 4 Sept 2026
18 shares @ US$79.37 0.0000% mcap 24.8% of flow Common Stock SEC144:0001628280-26-060748
● Shareholder · Executives · 4 Sept 2026
912 shares @ US$79.37 0.0024% mcap 24.3% of flow Common Stock SEC144:0001628280-26-060746
● Shareholder · Executives · 4 Sept 2026
759 shares @ US$79.37 0.0020% mcap 24.3% of flow Common Stock SEC144:0001628280-26-060747
▼ Director · Executives · 1 Sept 2026
70 shares @ US$79.95 0.0002% mcap 0.0% of flow Common Stock SEC:0001591747-26-000002:0
▼ Director · Executives · 1 Sept 2026
58 shares @ US$79.95 0.0002% mcap 0.0% of flow Common Stock SEC:0001591747-26-000002:1
▼ Director · Executives · 1 Sept 2026
1 shares @ US$79.95 0.0000% mcap 0.0% of flow Common Stock SEC:0001591747-26-000002:2
▼ Director · Executives · 2 Sept 2026
26,542 shares @ US$80.17 0.070% mcap 6.0% of flow Common Stock SEC:0001591747-26-000002:3
▼ Director · Executives · 2 Sept 2026
22,090 shares @ US$80.17 0.058% mcap 5.0% of flow Common Stock SEC:0001591747-26-000002:4
▼ Director · Executives · 2 Sept 2026
511 shares @ US$80.17 0.0013% mcap 0.1% of flow Common Stock SEC:0001591747-26-000002:5
▼ Director · Executives · 2 Sept 2026
9 shares @ US$80.98 0.0000% mcap 0.0% of flow Common Stock SEC:0001591747-26-000002:7
▼ Director · Executives · 2 Sept 2026
2 shares @ US$80.98 0.0000% mcap 0.0% of flow Common Stock SEC:0001591747-26-000002:8
▼ Director · Executives · 3 Sept 2026
2,810 shares @ US$79.98 0.0073% mcap 0.6% of flow Common Stock SEC:0001591747-26-000002:9
▼ Director · Executives · 3 Sept 2026
2,339 shares @ US$79.98 0.0061% mcap 0.5% of flow Common Stock SEC:0001591747-26-000002:10
▼ Director · Executives · 3 Sept 2026
54 shares @ US$79.98 0.0001% mcap 0.0% of flow Common Stock SEC:0001591747-26-000002:11
▼ Director · Executives · 2 Sept 2026
10 shares @ US$80.98 0.0000% mcap 0.0% of flow Common Stock SEC:0001591747-26-000002:6
● Shareholder · Executives · 3 Sept 2026
6,822 shares @ US$80.05 0.018% mcap 75.7% of flow Common Stock SEC144:0001628280-26-060502
● Shareholder · Executives · 3 Sept 2026
54 shares @ US$80.05 0.0001% mcap 75.2% of flow Common Stock SEC144:0001628280-26-060507
● Shareholder · Executives · 3 Sept 2026
2,810 shares @ US$80.05 0.0073% mcap 75.7% of flow Common Stock SEC144:0001628280-26-060504
● Shareholder · Executives · 3 Sept 2026
2,339 shares @ US$80.05 0.0061% mcap 75.7% of flow Common Stock SEC144:0001628280-26-060505
◇ Chief Operating Officer · Executives · 24 Aug 2026
300 shares @ US$13.50 0.0001% mcap 0.3% of flow Common Stock SEC:0001193125-26-369179:0
▼ Chief Operating Officer · Executives · 24 Aug 2026
300 shares @ US$82.5333 0.0008% mcap 1.8% of flow Common Stock SEC:0001193125-26-369179:1
25 of 204 declarations
Load more (179 remaining) 关于 Disc Medicine, Inc. Disc Medicine, Inc. 是一家生物制药公司,专注于开发治疗血液疾病的创新疗法。该公司在纳斯达克上市,股票代码为IRON。